Table 3 Demographic and clinical characteristics of rheumatoid arthritis and gout synovial tissue (quantitative polymerase chain reaction)
From: FMS-related tyrosine kinase 3 ligand (Flt3L)/CD135 axis in rheumatoid arthritis
|  | Rheumatoid arthritis (n = 22) | Gout (n = 12) |
|---|---|---|
Age (years) | 60 ± 8 | 62 ± 14 |
Sex, female/male | 13/9 | 2/10 |
Disease duration (years) | 13 ± 14 | 2.3 ± 1.7 |
Swollen joint count | 7 ± 5 | 2 ± 3 |
C-reactive protein (mg/l) | 20 ± 26 | 36 ± 31 |
Disease Activity Score in 28 joints | 5.0 ± 1.2 | nd |
Erythrocyte sedimentation rate (mm/hour) | 38 ± 31 | 35 ± 20 |
IgM-RF (kU/l) | 464 ± 1366 | nd |
Anti-CCP (kAU/ml) | 2197 ± 3475 | nd |
Number taking NSAIDS (positive/negative) | 12/22 | 4/12 |
Number taking corticosteroids (positive/negative) | 9/22 | 1/12 |
Number taking DMARDs (positive/negative) | 12/22 | 0/12 |
Number taking anti-tumor necrosis factor (positive/negative) | 6/22 | 0/12 |